12007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J, 2007,28 : 1462-1536.
2Koren MJ, Devereux RB, Casale PN, et al. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med, 1991, 114:345-352.
3Levy D, Crarrison RJ, Savage DD, et al. Prognostic implications of echocardiographically-determined left ventricular mass in the Framimgham Heart study. N Engl J Med, 1990, 322:1561 - 1566.
4Liao Y, Cooper RS, McGee DL, et al. The relative effects of left ventricular hypertrophy, coronary artery disease, and ventricular dysfunction on survival among black adults. JAMA, 1995,273: 1592-1597.
5Vakili BA, Okin PM, Devereux RB. Prognostic significance of left ventricular hypertrophy. Am Heart J, 2001, 141:334-341.
6Devereux RB, Palmieri V, Liu JE, et al. Progressive hypertrophy regression with sustained pressure reduction in hypertension: the losartan intervention for endpoint reduction study. J Hypertens, 2002,20 : 1445-1450.
7Okin PM, Devereux RB, Jem S, et al, Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and the prediction of major cardiovascular events. JAMA, 2004,292:2343-2349.
8Murphy ML, Thenabadu PN, de Soyza N, et al. Reevaluation of electrocardiographic criteria for left, right and combined cardiac ventricular hypertrophy. Am J Cardiol, 1984, 53 : 1140-1147.
9Casale PN, Devereux RB, Alonso DR, et al. Improved sexspecific criteria of left ventricular hypertrophy for clinical and computer interpretation of electrocardiograms: validation with autopsy findings. Circulation, 1987, 75 : 565-572.
10Fleg JL. Alterations in cardiovascular structure and function with advancing age. Am J Cardiol, 1986,57:33c-44c.
